Volume 19 Supplement 1
12th European Headache Federation Congress jointly with 32nd National Congress of the Italian Society for the Study of Headaches
Publication costs for this supplement were funded by the 12th European Headache Federation Congress and the 32nd National Congress of the Italian Society for the Study of Headaches. PM has received grants from Allergan, Novartis and Teva. He received contributions to research from Allergan, Novartis and Teva, and acted on cosultant activities for Allergan. PM is an employee of Springer Nature. RB has received grants from Allergan, Teva, Dr. Reddy and Trigemina. He also acted on consultant activities for Avanir, Biohaven, Allergan, Teva, Alder, Alkermis, ATI, Depomed, Electocore, Neurlief, Pernix, Pervept, Tekeda and Trigemina. FP declares no competing interest.
Florence, Italy28-30 September 2018
Edited by Paolo Martelletti, Rami Burstein and Francesco Pierelli.
2017 Journal Metrics
30 days from submission to first decision
51 days from submission to acceptance
19 days from acceptance to publication
685 Altmetric Mentions
- ISSN: 1129-2377